Keyword Connections

glp-1

Journals

1

1 Diabetes, obesity & metabolism

Research Groups

0

No Research Group Connected

Bibliographies

23

1 Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11.

2 The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus.

3 The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.

4 Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes

5 Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study

6 GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

7 A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

8 Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.

9 Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis.

10 Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.

11 A Role for GLP-1 in Treating Hyperphagia and Obesity

12 a clinical review of glp-1 receptor agonists: efficacy and safety in diabetes and beyond

13 inflammation meets metabolic disease: gut feeling mediated by glp-1

14 activation of glp-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-catenin

15 serotonergic modulation of the activity of glp-1 producing neurons in the nucleus of the solitary tract in mouse

16 choosing between glp-1 receptor agonists and dpp-4 inhibitors: a pharmacological perspective

17 glp-1 based combination therapy for obesity and diabetes

18 loss of dorsomedial hypothalamic glp-1 signaling reduces bat thermogenesis and increases adiposity

19 glp-1 based therapeutics: simultaneously combating t2dm and obesity

20 combined msc and glp-1 therapy modulates collagen remodeling and apoptosis following myocardial infarction

21 incretins role in latent autoimmune diabetes of adults pathogenesis, the possibility of therapy with combination of glucagon-like peptide-1 agonist (glp-1) and insulin.

22 Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.

23 Evaluating the Efficacy of ChatGPT vs. Google Gemini in Generating Patient Education Materials for GLP-1 Receptor Agonists (Semaglutide, Liraglutide, Tirzepatide): A Cross-Sectional Study.